Medtronic, Inc. (NYSE:MDT): The regulator of The Federal Drug Administration wrote a warning letter to Medtronic, Inc., which was posted on their website. It concerned the firm's response to the findings in an investigation which, according to the FDA ...
Read the whole article...
No comments:
Post a Comment